20 February 2017
: Case report
Pulmonary Kaposi Sarcoma with Osseous Metastases in an Human Immunodeficiency Virus (HIV) Patient: A Remarkable Response to Highly Active Antiretroviral Therapy
Unusual clinical course, Challenging differential diagnosis, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Ahmed Dirweesh1EF*, Muhammad Yasir Khan1EF, Shaikh Fawad Hamiz1EF, Nigahus Karabulut2EFDOI: 10.12659/AJCR.902355
Am J Case Rep 2017; 18:181-185
Abstract
BACKGROUND: Kaposi sarcoma (KS) is known to involve the mucocutaneous tissues and the aero-digestive tracts. In acquired immune deficiency syndrome (AIDS) patients, KS has an aggressive course and carries poor prognosis. We present a case of pulmonary KS with osseous metastases as the first presentation of human immunodeficiency virus (HIV) infection in a young male. The lesions impressively decreased in size and numbers following initiation of highly active antiretroviral therapy (HAART).
CASE REPORT: A 34-year-old heterosexual male presented with a one month history of cough and 15–20 pound weight loss within six months. Examination revealed oral thrush, decreased breath sounds and crackles on the right lower lung base. Imaging showed a large right perihilar mass with multiple lytic lesions involving thoracic and lumber vertebrae, ribs, sternum, and clavicles. Blood and sputum cultures, smears for acid fast bacilli, and a QUANTIferon gold test were all negative. He tested positive for HIV and his CD4 count was 7 cells/uL. Bronchoscopy with biopsy was unrevealing. Pathology of the right hilar mass was diagnostic of KS. Following initiation of antiretroviral therapy his condition dramatically improved; repeat chest CT scan showed marked regression of the bony and pulmonary lesions.
CONCLUSIONS: The dual action of HAART on the recovery of the immune system and against human herpes virus 8 (HHV-8) may essentially cause regression of KS lesions.
Keywords: AIDS Serodiagnosis, Anti-HIV Agents, HIV, Sarcoma, Kaposi
816 7
In Press
21 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941337
21 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941422
21 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941599
21 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941877
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250